Alvotech, a global biotech company focused on developing biosimilar medicines, announced the acquisition of the Ivers-Lee Group, a Swiss family-owned business specializing in pharmaceutical assembly ...

"Alvotech has a best-in-class biosimilars manufacturing site in Iceland, both for drug substance and drug products. At the same time, our strong in-house R&D capabilities have put Alvotech in a ...

Sandoz has started construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia. This $440 million project brings the company’s total ...

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will significantly improve ecological footprint and help ...

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...

Biosimilar Manufacturing Expansion: Major biopharmaceutical companies expanding manufacturing facilities to meet growing biosimilar demand, including strategic partnerships such as Biocon Ltd. and ...

Richard Saynor, Chief Executive Officer of Sandoz, said: “The first half of the year marked another phase of good progress for Sandoz. Strong underlying sales growth was underpinned by the ...

Biologic medicines—drugs with complex molecules developed in living cells—have saved lives and improved the quality of life for millions of Americans. Yet despite their value, problems in the industry ...

Good morning, and welcome to the Sandoz session of the 44th JPMorgan Healthcare Conference. My name is Sophia Graeff Buhl Nielsen. I'm an analyst here at JPMorgan on the European pharma and biotech ...

India has firmly established itself as the world's major producer of generic drugs. It is currently ranked third in pharmaceutical production by volume, with a CAGR of 9.43% over the past nine years.